News at USA Health

The event, being held as part of Child Passenger Safety Seat Week, is sponsored by USA Health Children’s & Women’s Hospital and Tobias & Comer Law.

“Our preliminary studies make strong suggestions for a pathobiological involvement of nicotine exposure in prostate cancer aggressiveness and therapy resistance.”

USA Health is the first health system in Alabama and the upper Gulf Coast region to earn the three-year accreditation.

The Samuel Hassenbusch Young Neurosurgeon Award is given to the top socioeconomic abstract selected from among the thousands of abstracts submitted to the Congress of Neurological Surgeons annual meeting.

The gift includes $23,900 in proceeds from the recent Piggly Wiggly Golf Tournament in Mobile and a matching donation from longtime MCI supporter Abraham A. Mitchell.

Radiation oncologist Joseph Jones, M.D., works with a multidisciplinary team to deliver the most advanced therapies for cancer patients.

All four locations have been performing continuously since 2018 to sustain recognition as Patient-Centered Medical Homes, meeting standards that ultimately translate to better experiences and outcomes for patients.

USA Health is teaming with Jeffrey St. John, M.D., of Vision Partners to provide high quality care using state-of-the-art equipment.

“Our ultimate goal for this research is to make clear the biological and molecular mechanisms that are critical to rickettsial transmission by fleas so we can better understand the epidemiology of flea-borne rickettsial diseases and identify novel points of intervention,” Macaluso said.

Funded by a grant from the Centers for Disease Control and Prevention, the Community Health Workers project is a collaboration between the USA Center for Healthy Communities and the Mobile County Health Department.

Nabin R. Karki, M.D., will focus on treating patients with prostate cancer, kidney cancer, bladder cancer and testicular cancer.

Led by Chandrani Sarkar, Ph.D., assistant professor of pathology, the research team has identified neuropeptide Y (NPY) derived from cancer cells as an independent regulator of colon cancer progression.